Skip to contentA
Aeternum Health, Inc.
A
AETNAeternum Health, Inc. Q2 2025 · 10-Q
Revenue$7.12K$7.12K−78.7% vs Q2 2024 Net Income-$105.86K-$105.86KN/M vs Q2 2024 EPS Diluted$0.00$0.00— vs Q2 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aeternum Health, Inc. · CIK 764630 · Engraved from SEC EDGAR
Operating Cash Flowderived$18,261— Margins · derivedGross margin-79.2%−176.7 pt vs Q2 2024
Operating margin-1245.6%−967.9 pt vs Q2 2024
Net margin-1486.3%−1137.8 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 19, 2025 · 50 d after period end